Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice.

Lehners A, Lange S, Niemann G, Rosendahl A, Meyer-Schwesinger C, Oh J, Stahl R, Ehmke H, Benndorf R, Klinke A, Baldus S, Wenzel UO.

Am J Physiol Renal Physiol. 2014 Aug 15;307(4):F407-17. doi: 10.1152/ajprenal.00262.2014. Epub 2014 Jul 2.

2.

Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis.

Gan PY, Steinmetz OM, Tan DS, O'Sullivan KM, Ooi JD, Iwakura Y, Kitching AR, Holdsworth SR.

J Am Soc Nephrol. 2010 Jun;21(6):925-31. doi: 10.1681/ASN.2009070763. Epub 2010 Mar 18.

3.

Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.

Odobasic D, Kitching AR, Semple TJ, Holdsworth SR.

J Am Soc Nephrol. 2007 Mar;18(3):760-70. Epub 2007 Jan 31.

4.

Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.

Souza AC, Bocharov AV, Baranova IN, Vishnyakova TG, Huang YG, Wilkins KJ, Hu X, Street JM, Alvarez-Prats A, Mullick AE, Patterson AP, Remaley AT, Eggerman TL, Yuen PS, Star RA.

Kidney Int. 2016 Apr;89(4):809-22. doi: 10.1016/j.kint.2015.12.043.

5.

Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase.

Odobasic D, Muljadi RC, O'Sullivan KM, Kettle AJ, Dickerhof N, Summers SA, Kitching AR, Holdsworth SR.

Arthritis Rheumatol. 2015 Jul;67(7):1868-80. doi: 10.1002/art.39109.

6.

Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.

Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, Ito T, Funahashi T.

Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1910-7. Epub 2007 Jul 12.

7.

Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.

Hayakawa S, Ohashi K, Shibata R, Kataoka Y, Miyabe M, Enomoto T, Joki Y, Shimizu Y, Kambara T, Uemura Y, Yuasa D, Ogawa H, Matsuo K, Hiramatsu-Ito M, van den Hoff MJ, Walsh K, Murohara T, Ouchi N.

J Am Soc Nephrol. 2015 Mar;26(3):636-46. doi: 10.1681/ASN.2014020210. Epub 2014 Jul 28.

8.

Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function.

Odobasic D, Kitching AR, Yang Y, O'Sullivan KM, Muljadi RC, Edgtton KL, Tan DS, Summers SA, Morand EF, Holdsworth SR.

Blood. 2013 May 16;121(20):4195-204. doi: 10.1182/blood-2012-09-456483. Epub 2013 Mar 18.

9.

αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy.

Shi M, Flores B, Gillings N, Bian A, Cho HJ, Yan S, Liu Y, Levine B, Moe OW, Hu MC.

J Am Soc Nephrol. 2016 Aug;27(8):2331-45. doi: 10.1681/ASN.2015060613. Epub 2015 Dec 23.

10.

Endothelial function in a mouse model of myeloperoxidase deficiency.

Golubinskaya V, Brandt-Eliasson U, Gan LM, Kjerrulf M, Nilsson H.

Biomed Res Int. 2014;2014:128046. doi: 10.1155/2014/128046. Epub 2014 Feb 23.

11.

Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury.

Kubota K, Saiwai H, Kumamaru H, Maeda T, Ohkawa Y, Aratani Y, Nagano T, Iwamoto Y, Okada S.

Spine (Phila Pa 1976). 2012 Jul 15;37(16):1363-9. doi: 10.1097/BRS.0b013e31824b9e77.

PMID:
22322369
12.

CCR5 deficiency aggravates crescentic glomerulonephritis in mice.

Turner JE, Paust HJ, Steinmetz OM, Peters A, Meyer-Schwesinger C, Heymann F, Helmchen U, Fehr S, Horuk R, Wenzel U, Kurts C, Mittrücker HW, Stahl RA, Panzer U.

J Immunol. 2008 Nov 1;181(9):6546-56.

13.

Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion.

Matthijsen RA, Huugen D, Hoebers NT, de Vries B, Peutz-Kootstra CJ, Aratani Y, Daha MR, Tervaert JW, Buurman WA, Heeringa P.

Am J Pathol. 2007 Dec;171(6):1743-52. Epub 2007 Nov 30.

14.

Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants.

Mendoza MG, Castillo-Henkel C, Medina-Santillan R, Jarillo Luna RA, Robles HV, Romo E, Rios A, Escalante B.

Nephrology (Carlton). 2008 Jun;13(3):218-27. doi: 10.1111/j.1440-1797.2007.00897.x.

PMID:
18315704
15.

Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction.

Askari AT, Brennan ML, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL, Penn MS.

J Exp Med. 2003 Mar 3;197(5):615-24.

16.

Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury.

Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, Muramatsu T.

J Immunol. 2001 Sep 15;167(6):3463-9.

17.

Direct activation of glomerular endothelial cells by anti-moesin activity of anti-myeloperoxidase antibody.

Nagao T, Suzuki K, Utsunomiya K, Matsumura M, Saiga K, Wang PC, Minamitani H, Aratani Y, Nakayama T, Suzuki K.

Nephrol Dial Transplant. 2011 Sep;26(9):2752-60. doi: 10.1093/ndt/gfr032. Epub 2011 Mar 5.

PMID:
21378392
18.

Lung Neutrophilia in Myeloperoxidase Deficient Mice during the Course of Acute Pulmonary Inflammation.

Kremserova S, Perecko T, Soucek K, Klinke A, Baldus S, Eiserich JP, Kubala L.

Oxid Med Cell Longev. 2016;2016:5219056. doi: 10.1155/2016/5219056. Epub 2016 Feb 21.

19.

Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.

Naito T, Ma LJ, Yang H, Zuo Y, Tang Y, Han JY, Kon V, Fogo AB.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F683-91. doi: 10.1152/ajprenal.00503.2009. Epub 2009 Dec 30.

20.

Exaggerated renal pathology of partial ablation-induced chronic renal failure in eNOS deficient mice.

Yamashita C, Tazawa N, Ohkita M, Matsumura Y.

Biol Pharm Bull. 2008 May;31(5):1029-31.

Supplemental Content

Support Center